• Home
  • Careers

Company Vision

To redefine the life of the spinal cord injury patient.

InVivo in the News

Press Releases

InVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of Directors November 12, 2019

InVivo Therapeutics Provides Enrollment Update for INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury October 22, 2019

InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord July 16, 2019

CEO's Perspective

“As evidenced by the passing of the 21st Century Cures Act, regulators and policy makers have recently highlighted the benefits and utility of Real-World Evidence (RWE) as it pertains to the Food and Drug Administration (FDA) regulatory decision-making for medical devices. RWE is derived from Real World Data (RWD) collected outside of a traditional clinical trial and includes sources such as patient registries. InVivo is committed to providing regulatory agencies with a comprehensive benchmark comparator dataset using RWE to help support the assessment of the safety and probable benefit of its Neuro-Spinal Scaffold™. ” For full text, click here.

Mark Perrin, CEO and Chairman, 5/30/2017

Research & Clinical Development Preview

_0006_Pressure ulcers

Click here to learn more

Learn More About Our Clinical Trials
Menu